This editorial refers to 'Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: a subanalysis of the randomized EchoCRT trial' † , by J.J. Bax et al., on page 720.
Cardiac resynchronization therapy (CRT) is a highly effective therapy for chronic heart failure (CHF) patients with bundle branch block and broad QRS >130 ms. 1 Some years ago, single-centre studies suggested that CHF patients with a QRS width <120 ms but evidence of mechanical dyssynchrony might also be CRT candidates. 2 Five randomized trials have subsequently addressed the question of whether the indication for CRT should be extended to CHF patients with narrow QRS width. 3 To cut a long story short, all five trials failed along the way. EchoCRT was the largest trial with 809 randomized patients with a QRS <130 ms and echocardiographic evidence of mechanical dyssynchrony, verified in a central core lab and defined as the maximal difference in timing of segmental myocardial contraction on tissue Doppler imaging or speckle-tracking radial strain. The study was terminated early due to excess mortality in the CRT group, which was the basis for the contraindication for CRT in this population. 4 The study result also reminded us that CRT can be harmful and detrimental for unsuitable patients. 5, 6 However, the exact reasons for the negative CRT effect have not been completely determined yet. Meanwhile, three EchoCRT substudies have been published which may help to better understand the results of EchoCRT. In a pre-specified subgroup analysis of the EchoCRT trial, Steffel et al. found no evidence for benefit in the subgroup with borderline QRS duration of 120-130 ms (17% of all patients) when compared with patients with shorter QRS duration. 7 This implies that CRT should only be offered to patients with broader QRS duration >130 ms and fits well with the recently proposed new cut-off for left bundle branch block (LBBB) of 130 ms in women and 140 ms in men. 8 Gorscan et al. analysed the changes in dyssynchrony from baseline to 6-month follow-up in a subset of 614 EchoCRT patients. 9 After 6 months, improvement in dyssynchrony was documented in only 24% of all patients irrespective of randomization to CRT. The majority showed persistent dyssynchrony, which was associated with worse outcome (death or HF-related hospitalization). The authors speculated that CRT might even worsen baseline dyssynchrony, leading to a further decrease in global contractility and an increased level of arrhythmogenicity. 10, 11 In this issue of the journal, Bax et al. present the results of another EchoCRT subanalysis which focuses on left ventricular (LV) function as assessed by LV global longitudinal strain (LVGLS) by 2D speckletracking echocardiography. 12 LVGLS represents the averaged longitudinal strain from 18 ventricular segments and has recently been proposed as a highly sensitive and reproducible prognostic marker. 13 Reduced segmental longitudinal strain correlates well with the extent of regional myocardial fibrosis or necrosis. When patients were categorized according to LVGLS quartiles, the primary endpoint occurred more frequently in the 186 patients in the lowest LVGLS quartile (<6.2%) treated with CRT-ON vs. CRT-OFF (45.6% vs. 28.7%, P = 0.009), whereas in 569 patients with LVGLS > _6.2% no differences were observed between CRT-OFF and CRT-ON (23.7% vs. 24.5%; P = 0.62). Thus, the possible negative impact of CRT may mainly affect the 'sickest' patients with presumably more extensive structural myocardial damage. These patients also presented with larger ventricles and lower LV ejection fraction. LVGLS was the only LV function parameter independently associated with worse clinical outcome in the multivariate analysis. The analysis by Bax et al. and the previous substudies of EchoCRT together may help to complete another important missing part of the CRT puzzle: patients without significant electrical delay (QRS <130 ms) are NOT candidates for electrical resynchronization as their dyssynchrony is most probably due to structural damage and is unlikely to improve by CRT. In these patients, LV stimulation by CRT may aggravate pre-existing non-electrical dyssynchrony and this may further deteriorate LV function. The artificially induced deleterious strain on the myocardium may be tolerated by the 'healthier' patients in the higher LVGLS quartiles, whereas in the 'sicker' patients with the lowest LVGLS, it may exert disastrous effects with an increase in short-term mortality.
EchoCRT hypothesized that 'any' dyssynchrony documented by echocardiography can be resolved by electrical stimulation. The study selected patients with primarily 'non-electrical dyssynchrony', which is rather a reflection of the overall poor cardiac condition with myocardial fibrosis and/or subclinical chronic ischaemia, but not necessarily the consequence of delayed electrical activation responsive to electrical stimulation.
14 True electrical dyssynchrony amenable to CRT can be identified by typical strain patterns with the identification of early systolic pre-stretch and post-systolic shortening (Figure 1 ).
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However, EchoCRT relied on absolute time delays to identify dyssynchrony and was not designed to analyse the specific spatial-temporal patterns. We would like to encourage the authors to conduct a further analysis focusing on the dyssynchrony patterns instead of temporal delays. There is strong evidence that the successful identification and correction of such a typical electrical dyssynchrony pattern by CRT will translate into improved outcome. 16 Finally, the retrospective analysis by Bax et al. 12 also provides important data for risk stratification in patients with LV systolic dysfunction by echocardiography and suggests that assessment of LVGLS has an independent and additive prognostic value in comparison with the traditional assessment of LVEF. 17 This should encourage us to use this new parameter routinely in addition to LVEF, particularly in patients with advanced heart failure.
Conclusions
The EchoCRT investigators should be congratulated for providing a better understanding of the pathophysiology of CRT by emphasizing the limitations and the possible harm of CRT. CRT is an indispensable and live-saving therapy, but only for well selected patients where the electrical stimulus finds an appropriate electrical delay suited for resynchronization. The sickest patients with most depressed LV function need our particular attention as they may not be able to withstand the extra strain introduced by inappropriate CRT.
